Neurotechnologies as tools for cognitive rehabilitation in stroke patients.


Journal

Expert review of neurotherapeutics
ISSN: 1744-8360
Titre abrégé: Expert Rev Neurother
Pays: England
ID NLM: 101129944

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 6 9 2020
medline: 29 6 2021
entrez: 5 9 2020
Statut: ppublish

Résumé

Cognitive impairments are one of the most common remaining symptoms after a stroke. The use of neurotechnologies to enhance cognitive performance is a rapidly emerging field with encouraging results. Here, the authors empirically review the respective literature and critically discuss the technologies that are currently most often used for cognitive enhancement in stroke patients, which are computerized cognitive training, virtual reality, noninvasive brain stimulation and brain-computer interfaces. The authors describe their advantages/disadvantages and the challenges and limitations to overcome. Although the current results are promising, more research is needed to be able to make conclusive statements and translate these approaches successfully in daily clinical life. Multidiscipline collaborations could aid to improve current neurotechnologies and provide guidelines for future implementations.

Identifiants

pubmed: 32887528
doi: 10.1080/14737175.2020.1820324
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1249-1261

Auteurs

Laurijn R Draaisma (LR)

Defitech Chair of Clinical Neuroengineering, Center for Neuroprosthetics (CNP) and Brain Mind Institute (BMI), Swiss Federal Institute of Technology (EPFL) , Geneva, Switzerland.
Defitech Chair of Clinical Neuroengineering, Clinique Romande de Réadaptation, Center for Neuroprosthetics (CNP) and Brain Mind Institute (BMI, Swiss Federal Institute of Technology (EPFL Valais) , Sion, Switzerland.

Maximilian J Wessel (MJ)

Defitech Chair of Clinical Neuroengineering, Center for Neuroprosthetics (CNP) and Brain Mind Institute (BMI), Swiss Federal Institute of Technology (EPFL) , Geneva, Switzerland.
Defitech Chair of Clinical Neuroengineering, Clinique Romande de Réadaptation, Center for Neuroprosthetics (CNP) and Brain Mind Institute (BMI, Swiss Federal Institute of Technology (EPFL Valais) , Sion, Switzerland.

Friedhelm C Hummel (FC)

Defitech Chair of Clinical Neuroengineering, Center for Neuroprosthetics (CNP) and Brain Mind Institute (BMI), Swiss Federal Institute of Technology (EPFL) , Geneva, Switzerland.
Defitech Chair of Clinical Neuroengineering, Clinique Romande de Réadaptation, Center for Neuroprosthetics (CNP) and Brain Mind Institute (BMI, Swiss Federal Institute of Technology (EPFL Valais) , Sion, Switzerland.
Clinical Neuroscience, University of Geneva Medical School , Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH